TrialScope Turns to NOL Program, Venture Fund Investment


June 24, 2019

As seen on – Posted June 24, 2019 – Original Article

TRENTON, NJ (June 24, 2019) – A combination of resources from the New Jersey Economic Development Authority (NJEDA), a growth equity investment from three venture capital firms including Edison Partners, and proximity to numerous global pharmaceutical giants has helped Hudson County-based TrialScope support pharmaceutical companies conducting clinical trials around the world.

Operating out of an office in Jersey City, TrialScope helps pharmaceutical companies through the clinical-trial regulatory approvals process. 

Continued on